Resmed Inc
NYSE:RMD
Resmed Inc
NYSE:RMD
Price:
214.9 USD
-0.05%
Market Closed
Updated:
May 2, 2024
Resmed Inc
Revenue
|
Resmed Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Resmed Inc
NYSE:RMD
|
Revenue
$4.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Resmed Inc
Revenue Breakdown
Breakdown by Geography
Resmed Inc
Resmed Inc
|
Total Revenue:
4.2B
USD
|
|
United States:
2.7B
USD
|
|
Rest Of World:
1.5B
USD
|
Breakdown by Segments
Resmed Inc
Resmed Inc
|
Total Revenue:
4.2B
USD
|
|
Sleep And Respiratory:
3.7B
USD
|
|
Software As A Service:
498m
USD
|
See Also
What is Resmed Inc's Revenue?
Revenue
4.6B
USD
4.6B
USD
Based on the financial report for Mar 31, 2024, Resmed Inc's Revenue amounts to 4.6B USD.
What is Resmed Inc's Revenue growth rate?
Revenue CAGR 10Y
11%
11%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Resmed Inc have been 14% over the past three years , 13% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
